van Deelen Bob A J, van den Bemt Patricia M L A, Egberts Toine C G, van 't Hoff Annelies, Maas Huub A A M
Department of Geriatric Medicine, Twenteborg Hospital, Almelo, The Netherlands.
Drugs Aging. 2005;22(4):353-60. doi: 10.2165/00002512-200522040-00007.
Atrial fibrillation is an indication for oral anticoagulation treatment. Maintaining the International Normalized Ratio (INR) within the therapeutic range minimises thromboembolic and bleeding complications. We have investigated whether cognitive capacity affects control of anticoagulation in elderly patients with atrial fibrillation.
A retrospective study was conducted to investigate the association between cognitive impairment and control of anticoagulation. Patients > or =70 years of age with atrial fibrillation using acenocoumarol (nicoumalone) as anticoagulant were included. All patients were monitored by the Anticoagulation Clinic in the Midden-Brabant region in the Netherlands. The cognitive function of all patients was assessed using the Mini-Mental State Examination (MMSE) on the index date. INR values were obtained from the year preceding the index date. Patients with an MMSE score <23 were defined as cognitively impaired. The primary outcome of the study was the incidence of an INR value within the therapeutic range of 2.0-3.4 during < or =70% of treatment time in the year prior to the cognitive function assessment. The secondary endpoint was the number of patients with an INR <2.0 or > or =6.0 at least once during this year. Logistic regression analysis was used to evaluate the association between cognitive function and control of anticoagulation.
A total of 152 patients were included in the study. An MMSE score <23 was associated with an inadequate INR control (odds ratio [OR] 2.77; 95% CI 1.13, 6.74). After correction for hospital admission and change of possibly interacting medication (both also associated with inadequate INR control), this association remained statistically significant. Significantly more patients with an MMSE score <23 had one or more INR values of six or higher (OR 3.06; 95% CI 1.14, 8.18).
In elderly people with atrial fibrillation using oral anticoagulation, an MMSE score <23 is independently associated with an inadequate INR control, mainly because of an increased number of supratherapeutic INR values. This finding should be taken into account when making decisions about use of oral anticoagulants in the elderly.
心房颤动是口服抗凝治疗的适应症。将国际标准化比值(INR)维持在治疗范围内可使血栓栓塞和出血并发症的发生风险降至最低。我们研究了认知能力是否会影响老年心房颤动患者的抗凝控制情况。
开展一项回顾性研究,以调查认知障碍与抗凝控制之间的关联。纳入年龄≥70岁、使用醋硝香豆素(尼可香豆素)作为抗凝剂的心房颤动患者。所有患者均由荷兰中布拉班特地区的抗凝门诊进行监测。在索引日期使用简易精神状态检查表(MMSE)对所有患者的认知功能进行评估。INR值取自索引日期前一年。MMSE评分<23分的患者被定义为认知障碍。该研究的主要结局是在认知功能评估前一年治疗时间≤70%期间,INR值处于2.0 - 3.4治疗范围内的发生率。次要终点是该年度内至少有一次INR<2.0或≥6.0的患者数量。采用逻辑回归分析来评估认知功能与抗凝控制之间的关联。
共有152例患者纳入该研究。MMSE评分<23分与INR控制不佳相关(比值比[OR]为2.77;95%置信区间为1.13, 6.74)。在校正住院情况以及可能相互作用的药物变化(二者也与INR控制不佳相关)后,这种关联仍具有统计学意义。MMSE评分<23分的患者中,有显著更多患者的INR值有一次或多次达到6或更高(OR为3.06;95%置信区间为1.14, 8.18)。
在使用口服抗凝剂的老年心房颤动患者中,MMSE评分<23分与INR控制不佳独立相关,主要原因是治疗性INR值升高。在对老年人使用口服抗凝剂做出决策时,应考虑这一发现。